HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arne Holmgren Selected Research

Glutaredoxins

1/2022Mitochondrial depletion of glutaredoxin 2 induces metabolic dysfunction-associated fatty liver disease in mice.
1/2017Iron-sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microglia.
12/2015Glutaredoxin mediated redox effects of coenzyme Q10 treatment in type 1 and type 2 diabetes patients.
4/2014Plasma glutaredoxin activity in healthy subjects and patients with abnormal glucose levels or overt type 2 diabetes.
11/2008Glutaredoxin systems.
3/2008Expression pattern of human glutaredoxin 2 isoforms: identification and characterization of two testis/cancer cell-specific isoforms.
8/2004Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arne Holmgren Research Topics

Disease

33Neoplasms (Cancer)
11/2021 - 07/2005
8Infections
01/2019 - 01/2007
3Inflammation (Inflammations)
01/2022 - 11/2003
3Neurodegenerative Diseases (Neurodegenerative Disease)
12/2016 - 08/2007
3Cardiovascular Diseases (Cardiovascular Disease)
04/2010 - 03/2007
2Vascular Diseases (Vascular Disease)
01/2022 - 11/2003
2Atherosclerosis
01/2018 - 01/2007
2Neuroblastoma
10/2017 - 08/2015
2Neuroinflammatory Diseases
01/2017 - 02/2016
2Type 2 Diabetes Mellitus (MODY)
12/2015 - 04/2014
2Disease Progression
12/2015 - 01/2009
2Virus Diseases (Viral Diseases)
01/2014 - 01/2009
2Alzheimer Disease (Alzheimer's Disease)
10/2012 - 04/2010
2Muscular Diseases (Myopathy)
12/2010 - 04/2010
2Starvation
08/2009 - 05/2002
2Hypoxia (Hypoxemia)
11/2008 - 05/2008
2Interstitial Lung Diseases (Interstitial Lung Disease)
08/2004 - 11/2003
1Fatty Liver
01/2022
1Chemical and Drug Induced Liver Injury
10/2021
1Liver Failure
10/2021
1Staphylococcal Infections
01/2019
1Staphylococcal Skin Infections
01/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2017
1Multiple Sclerosis
01/2017
1Demyelinating Diseases (Demyelinating Disease)
01/2017
1Prostatic Neoplasms (Prostate Cancer)
01/2017
1Gram-Negative Bacterial Infections
01/2017
1Peritonitis
01/2017
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
12/2016
1Parasitemia
02/2016
1Rheumatoid Arthritis
01/2016
1Chronic Disease (Chronic Diseases)
01/2016

Drug/Important Bio-Agent (IBA)

18ThioredoxinsIBA
01/2020 - 11/2003
10Thioredoxin-Disulfide ReductaseIBA
01/2020 - 02/2004
10Proteins (Proteins, Gene)FDA Link
12/2016 - 05/2002
9EnzymesIBA
01/2022 - 11/2004
8AntioxidantsIBA
01/2020 - 07/2005
7GlutaredoxinsIBA
01/2022 - 08/2004
6Pharmaceutical PreparationsIBA
07/2014 - 04/2006
5ebselenIBA
01/2019 - 06/2002
5Selenoproteins (Selenoprotein)IBA
11/2018 - 12/2006
5SeleniumIBA
11/2018 - 12/2006
4SelenocysteineIBA
01/2020 - 04/2006
4Sulfhydryl Compounds (Thiols)IBA
11/2018 - 12/2006
4Selenium CompoundsIBA
04/2010 - 12/2006
3Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 06/2016
3MercuryIBA
10/2017 - 05/2010
3motexafin gadoliniumIBA
08/2011 - 04/2006
3Selenious Acid (Selenite)IBA
01/2011 - 09/2006
2Antiviral Agents (Antivirals)IBA
11/2021 - 01/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 04/2006
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 04/2014
2Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2019 - 04/2006
2IsoenzymesIBA
11/2018 - 05/2010
2GoldIBA
01/2018 - 01/2016
2Glutathione (Reduced Glutathione)IBA
10/2017 - 01/2017
2IronIBA
01/2017 - 01/2009
2SulfurIBA
01/2017 - 01/2009
2CurcuminIBA
01/2017 - 07/2005
2Superoxide Dismutase-1IBA
12/2016 - 11/2004
2Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2016 - 01/2013
2Cysteine (L-Cysteine)FDA Link
01/2016 - 12/2015
2Antineoplastic Agents (Antineoplastics)IBA
12/2015 - 02/2009
2Thyroid HormonesIBA
04/2010 - 01/2009
2Carrier Proteins (Binding Protein)IBA
03/2007 - 01/2007
1Glutathione Reductase (Glutathione-Disulfide Reductase)IBA
01/2022
1GlycogenIBA
01/2022
1LipidsIBA
01/2022
1Acetaminophen (Paracetamol)FDA LinkGeneric
10/2021
1Carboplatin (JM8)FDA LinkGeneric
01/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2019
1Dehydroascorbic AcidIBA
01/2019
1Vitamin K 3 (Menadione)FDA Link
01/2019
1DeoxyribonucleotidesIBA
01/2019
1Lipid PeroxidesIBA
11/2018
1methylselenic acidIBA
11/2018
1methaneselenolIBA
11/2018
1Protein Kinase CIBA
11/2018
1PlatinumIBA
01/2018
1eprenetapoptIBA
01/2018
1Insulin (Novolin)FDA Link
01/2018
1MetalsIBA
01/2018
1AndrogensIBA
01/2017
13-nitrotyrosineIBA
01/2017
1SilverIBA
01/2017
1Silybin (Lagosa)IBA
01/2017
1ResveratrolIBA
01/2017
1MelatoninIBA
01/2017
1Caspase 3 (Caspase-3)IBA
01/2016
1JNK Mitogen-Activated Protein KinasesIBA
01/2016
1PhytochemicalsIBA
01/2016
1Auranofin (Ridaura)FDA Link
01/2016
1Thioredoxin Reductase 1IBA
12/2015

Therapy/Procedure

8Therapeutics
01/2020 - 09/2006
3Chemoprevention
01/2010 - 04/2006
1Investigational Therapies (Experimental Therapy)
01/2019